Waiting
Traitement de la connexion…

Trial ends in Request Full Access Tell Your Colleague About Jove

Harnessing iPSC-Derived iTenocytes for Effective Cell-Based Therapy

March 1st, 2024
1,2,3, 1,2,3, 1,2,3,4,5
1Orthopaedic Stem Cell Research Laboratory, Cedars-Sinai Medical Center, 2Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, 3Department of Biomedical Sciences, Cedars-Sinai Medical Center, 4Department of Orthopedics, Cedars-Sinai Medical Center, 5Department of Surgery, Cedars-Sinai Medical Center

Summary
Automatic Translation

This article describes a procedure to produce iTenocytes by generating iPSC-derived mesenchymal stromal cells with combined overexpression of Scleraxis using a lentiviral vector and uniaxial stretching via a 2D bioreactor.

Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter